Source: PharmaTech

Bellwyck Pharma Services: PCI Acquires Bellwyck to Expand its Clinical Trial Services

PCI Pharma Services, a supply chain solutions provider, announced on Feb. 11, 2020 that it is acquiring Bellwyck Pharma Services, a primary and secondary packaging and labeling company for clinical trial and commercial drug markets headquartered in Toronto, Canada. The acquisition will bri

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
500-1.0K
Jeff Sziklai's photo - CEO of Bellwyck Pharma Services

CEO

Jeff Sziklai

CEO Approval Rating

90/100

Read more